Rachel Salazar
Lyndra Therapeutics (United States)(US)Mrag Americas (United States)(US)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Congenital Anomalies and Fetal Surgery, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Revised upper limb module for spinal muscular atrophy: Development of a new module(2016)353 cited
- → Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy(2017)217 cited
- → Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials(2015)213 cited
- → Six-minute walk test is reliable and valid in spinal muscular atrophy(2016)194 cited
- → Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool(2017)159 cited
- → Developmental milestones in type I spinal muscular atrophy(2016)134 cited
- → Ambulatory function in spinal muscular atrophy: Age-related patterns of progression(2018)122 cited
- → Clinical Variability in Spinal Muscular Atrophy Type III(2020)86 cited
- → Development of an academic disease registry for spinal muscular atrophy(2019)50 cited
- → Exploring mTOR inhibition as treatment for mitochondrial disease(2019)49 cited